Pharmaceutical manufacturing and Pharmacoeconomics
Pharmaceutical Manufacturing is the process used by businesses that produce pharmaceutical drugs. It faces on going pressure to accelerate innovation and quicken the pace at which they bring profitable products to market. The era of large pharmaceutical firms having a large number of manufacturing facilities is slowly coming to an end, and all businesses, regardless of size, are searching for methods to cut costs in order to compete in an environment that is becoming more challenging and unstable.
At various stages of medication development and commercialization, pharmacoeconomics is examined as part of decision-making processes. Increased decision-making issues and advancements in pharmacoeconomic research methods suggest that pharmacoeconomics will play a larger role in the new millennium. The pharmaceutical industry's businesses will suffer as a result of this.
- Cost-of-illness analysis
- Cost-benefit analysis
- Budget-impact analysis
- Cost-utility analysis
Related Conference of Pharmaceutical manufacturing and Pharmacoeconomics
29th International Conference on Neuropharmacology and Neurochemistry
5th International Conference on Biomedicine & Pharmacotherapy
7th World Congress on Advanced Clinical Trials and Clinical Research
4th International Forum on Pharmacovigilance and Regulatory Affairs
Pharmaceutical manufacturing and Pharmacoeconomics Conference Speakers
Recommended Sessions
- Pharmaceutical manufacturing and Pharmacoeconomics
- Advanced Pharmaceutical Technology
- Bioequivalence and Bioavailability
- Clinical Pharmacy and Pharmacy Practices
- Digital Pharma and Marketing
- Drug Discovery
- Drug Discovery
- Drug Discovery, Design & Development: Challenges and Approaches
- Nano medicine and Biomedical Application
- Novel Drug Delivery Systems, Biomarkers and Drug Targets
- Pharmaceutical Analysis
- Pharmaceutical Care and Health System
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Microbiology
- Pharmaceutical Nanotechnology
- Pharmacogenomics and Pharmacoepidemiology
- Pharmacology and Toxicology
- Technology in Pharma Sciences
- The future of Pharma R&D
Related Journals
Are you interested in
- Adaptive Trial Models - Clinical Trials Congress 2025 (Spain)
- Advanced Data Analytics - Clinical Trials Congress 2025 (Spain)
- Advanced Drug Delivery Systems - BIOMEDICINE 2025 (Netherlands)
- Advances in Omics Technologies - BIOMEDICINE 2025 (Netherlands)
- Advances in Vaccine Technology - BIOMEDICINE 2025 (Netherlands)
- Adverse Event Reporting through Mobile Health Tools - Euro Pharmacovigilance 2025 (Spain)
- AI in Clinical Research - Clinical Trials Congress 2025 (Spain)
- AI-Driven Signal Detection and Data Mining - Euro Pharmacovigilance 2025 (Spain)
- AI-Powered Pharmacovigilance - Clinical Trials Congress 2025 (Spain)
- Alzheimer’s and Parkinson’s Diseases - Neuropharmaceutics 2025 (Thailand)
- Artificial Intelligence in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Automation in Case Processing and Reporting - Euro Pharmacovigilance 2025 (Spain)
- Biotechnology in Drug Development - BIOMEDICINE 2025 (Netherlands)
- Blockchain Applications - Clinical Trials Congress 2025 (Spain)
- Blockchain Applications in Regulatory Data Integrity - Euro Pharmacovigilance 2025 (Spain)
- Brain Injury and Behavioral Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Brain Pathology and Oncology Research - Neuropharmaceutics 2025 (Thailand)
- Brain Stimulation and Imaging - Neuropharmaceutics 2025 (Thailand)
- Brain Structure and Function - Neuropharmaceutics 2025 (Thailand)
- Cardiovascular Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Clinical Neurophysiology and Stroke - Neuropharmaceutics 2025 (Thailand)
- Clinical Pharmacology and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Clinical Supply Chain Innovation - Clinical Trials Congress 2025 (Spain)
- CNS and Brain Disorders - Neuropharmaceutics 2025 (Thailand)
- Cognitive Neuroscience and Psychology - Neuropharmaceutics 2025 (Thailand)
- Data Integrity & Compliance - Clinical Trials Congress 2025 (Spain)
- Decentralized Trials - Clinical Trials Congress 2025 (Spain)
- Digital Health and Telemedicine - BIOMEDICINE 2025 (Netherlands)
- Digital Therapeutics Trials - Clinical Trials Congress 2025 (Spain)
- Digital Transformation in Drug Safety Operations - Euro Pharmacovigilance 2025 (Spain)
- Diversity in Enrollment - Clinical Trials Congress 2025 (Spain)
- eConsent & Retention Tools - Clinical Trials Congress 2025 (Spain)
- eSource & EDC Systems - Clinical Trials Congress 2025 (Spain)
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals - BIOMEDICINE 2025 (Netherlands)
- Ethics and Legal Challenges in Drug Safety Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Gene Therapy and Genetic Medicine - BIOMEDICINE 2025 (Netherlands)
- Global Harmonization of Regulatory Frameworks - Euro Pharmacovigilance 2025 (Spain)
- Global Regulatory Landscape - Clinical Trials Congress 2025 (Spain)
- Global Signal Management Systems and Standards - Euro Pharmacovigilance 2025 (Spain)
- Human Brain Mapping - Neuropharmaceutics 2025 (Thailand)
- Immunotherapy and Immunopharmacology - BIOMEDICINE 2025 (Netherlands)
- Infectious Diseases and Antimicrobial Resistance - BIOMEDICINE 2025 (Netherlands)
- Innovations in Biologics and Biosimilars - BIOMEDICINE 2025 (Netherlands)
- Inspection Readiness and Audit Best Practices - Euro Pharmacovigilance 2025 (Spain)
- Integration of PV with Quality and Regulatory Affairs - Euro Pharmacovigilance 2025 (Spain)
- Managing Safety Data in Multi-Region Submissions - Euro Pharmacovigilance 2025 (Spain)
- Master Protocol Strategies - Clinical Trials Congress 2025 (Spain)
- Metabolic Disorders and Endocrinology - BIOMEDICINE 2025 (Netherlands)
- Molecular and cellular neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Nanotechnology in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Neurobiology and Behaviors - Neuropharmaceutics 2025 (Thailand)
- Neurogenesis - Neuropharmaceutics 2025 (Thailand)
- Neuroimmunology and Neurological Infections - Neuropharmaceutics 2025 (Thailand)
- Neuroinformatics and Computational Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Neurological Disorders and Stroke - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and genetic aspects of CNS function - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurotherapeutics - BIOMEDICINE 2025 (Netherlands)
- Neurorehabilitation and Neural Repair - Neuropharmaceutics 2025 (Thailand)
- Neuroscience and Artificial Intelligence - Neuropharmaceutics 2025 (Thailand)
- Neurotherapeutics and Case Studies - Neuropharmaceutics 2025 (Thailand)
- Oncology Research and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Paediatric and Geriatric Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Patient-Centric Designs - Clinical Trials Congress 2025 (Spain)
- Patient-Centric Pharmacovigilance Strategies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacogenomics and Personalized Medicine - BIOMEDICINE 2025 (Netherlands)
- Pharmacovigilance and Drug Safety - BIOMEDICINE 2025 (Netherlands)
- Pharmacovigilance Compliance in Clinical Trials - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Accelerated Drug Approvals - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Gene and Cell Therapies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance Outsourcing and Vendor Oversight - Euro Pharmacovigilance 2025 (Spain)
- Pre- and post-synaptic function - Neuropharmaceutics 2025 (Thailand)
- Public Health and Pharmacoeconomics - BIOMEDICINE 2025 (Netherlands)
- Rare and Orphan Diseases: Therapeutic Approaches - BIOMEDICINE 2025 (Netherlands)
- Rare Disease Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Real-World Evidence in Post-Marketing Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Real-World Evidence Integration - Clinical Trials Congress 2025 (Spain)
- Regenerative Medicine and Tissue Engineering - BIOMEDICINE 2025 (Netherlands)
- Respiratory and Pulmonary Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Risk Management Planning and Benefit-Risk Assessment - Euro Pharmacovigilance 2025 (Spain)
- Risk-Based Monitoring - Clinical Trials Congress 2025 (Spain)
- Safety Labeling Changes and Regulatory Communication - Euro Pharmacovigilance 2025 (Spain)
- Safety Monitoring of Biologics and Biosimilars - Euro Pharmacovigilance 2025 (Spain)
- Stem Cells Role in Neuro-Biological Treatment - Neuropharmaceutics 2025 (Thailand)
- Synapse formation and neurotransmitter receptors - Neuropharmaceutics 2025 (Thailand)
- Synaptic Function and Dysfunction in Brain Diseases - Neuropharmaceutics 2025 (Thailand)
- Synaptic plasticity and memory - Neuropharmaceutics 2025 (Thailand)
- Synthetic Control Arms - Clinical Trials Congress 2025 (Spain)
- Virtual Trial Platforms - Clinical Trials Congress 2025 (Spain)
- Wearables & Remote Monitoring - Clinical Trials Congress 2025 (Spain)